title: Radiation dose escalation by percutaneous interstitial brachytherapy in locally advanced non-small cell lung cancer.
abstract: Management of locally advanced non-small cell lung cancer is associated with a poor overall survival using concurrent chemoradiotherapy. Therefore, newer approaches to treatment which enable dose escalation are warranted. Interstitial brachytherapy in lung is a new emerging concept with many distinct advantages. We report here a case of locally advanced non-small cell lung cancer with residual disease after conventional treatment. The patient was successfully treated using percutaneous interstitial brachytherapy and is disease-free at 18-month follow-up.
authors.affiliation: Department of Radiation Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: D N
authors.initials: DN
authors.lastname: Sharma
authors.forename: Amit
authors.initials: A
authors.lastname: Bahl
authors.forename: S
authors.initials: S
authors.lastname: Thulkar
authors.forename: G K
authors.initials: GK
authors.lastname: Rath
authors.forename: K S Jothy
authors.initials: KS
authors.lastname: Basu
authors.forename: A
authors.initials: A
authors.lastname: Bansal
authors.forename: P K
authors.initials: PK
authors.lastname: Julka
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001918:Brachytherapy / Q000379:methods*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000532:radiotherapy*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage